Archive

  • It's not you, it's me

    22 July 2024

    Sustainability and impact advocates can close the 'do-say gap' in 21st-century investing, writes Kieron Boyle

  • UK investors hit pause on sustainability labels

    03 July 2024

    The "painful" process of applying for a sustainability fund label in the UK has led some asset managers to pause applications, Michael Hurley reports

  • The role for TNFD in managing risk

    24 June 2024

    Business's impacts and dependencies on nature will only increase in salience. The tools and guidance available from the TNFD provide the perfect foundation for every business to start the journey, writes Judy Kuszewski

  • Impact valuations have 'come back down to Earth' after painful 2023, says M&G

    23 May 2024

    M&G's Positive Impact Fund's holdings were affected by rising costs and supply chain issues, Ben Constable-Maxwell tells Jennifer Forrest

  • The promise and perspectives of place-based investing

    16 May 2024

    Public and private capital can work together to drive investments that respond to the unique assets in a place, says Kieron Boyle

  • Going beyond the pale green

    08 May 2024

    Foresight's Irish impact fund aims that one-in-four of its investments will be 'pure green'. Jennifer Forrest reports

  • SFDR 'not working for impact VC funds'

    16 April 2024

    Venture capital funds are calling for special treatment in the updated version of SFDR. Jennifer Forrest reports

  • The legacy of legacies

    28 February 2024

    Family offices are uniquely positioned to lead the charge into impact investing, writes Kieron Boyle

  • Impact accounting framework released - with $236 per tonne cost of carbon

    23 February 2024

    The International Foundation for Valuing Impacts has published two draft methodologies - on greenhouse gas emissions and adequate wages. Michael Hurley speaks with Daniel Osusky

  • The future of eDNA

    16 February 2024

    Data provider NatureMetrics says demand is booming for its eDNA testing. Genevieve Redgrave visits its lab to find out more.